Related Experiment Video
Updated: Oct 29, 2025

Generation and Characterization of Right Ventricular Myocardial Infarction Induced by Permanent Ligation of the Right Coronary Artery in Mice
Published on: February 1, 2022
Long term effects of mild severity COVID‑19 on right ventricular functions
Fatih Akkaya1, Feyza Nur Topçu Yenerçağ2, Ahmet Kaya1
1Department of Cardiology, Ordu University, Ordu, Turkey.
Insights
Mild COVID-19 patients show long-term right ventricular dysfunction three months after infection. Echocardiography revealed reduced RV global longitudinal strain and free wall strain, indicating potential subclinical heart issues.
Area of Science:
- Cardiology
- Infectious Diseases
- Echocardiography
Background:
- COVID-19 is a novel infectious disease with known cardiovascular implications.
- Ventricular dysfunction, particularly in the right ventricle (RV), has been observed in COVID-19 patients.
Purpose of the Study:
- To evaluate RV function in mild COVID-19 patients three months post-infection.
- To compare RV function between mild COVID-19 survivors and healthy controls.
Main Methods:
- Single-center study involving 105 mild COVID-19 patients and 105 matched healthy controls.
- Assessment of RV function using conventional 2D echocardiography and 2D speckle-tracking echocardiography (STE).
- Comparison of echocardiographic parameters, including RV global longitudinal strain (RV-GLS) and RV free wall longitudinal strain (RV-FWLS).
Main Results:
- COVID-19 patients exhibited significantly higher RV diameters, systolic pulmonary artery pressure (sPAP), and RV myocardial performance index (RV MPI) compared to controls.
- Tricuspid annular plane systolic motion (TAPSE), RV fractional area change (RVFAC), and RV S' were significantly lower in the COVID-19 group.
- Significantly reduced RV-GLS and RV-FWLS were observed in COVID-19 patients compared to controls (p < 0.001).
- Negative correlations were found between RV-GLS/RV-FWLS and inflammatory markers (CRP, NLR, ferritin, PLR) and d-dimer.
Conclusions:
- Mild COVID-19 can lead to long-term subclinical right ventricular dysfunction.
- Reduced RV-GLS and RV-FWLS indicate persistent impairment in RV myocardial function three months post-infection.
- These findings highlight the importance of monitoring cardiac function in COVID-19 survivors.
Abstract:
Coronavirus disease 2019 (COVID-19) is a newly recognized infectious disease that has spread rapidly. COVID-19 has been associated with a number of cardiovascular involvements, including ventricular functions. The aim of our study was to evaluate the right ventricular functions of mild severity COVID-19 patients 3 months after, and compare them to the right ventricular functions of healthy volunteers. For this single-center study, data from 105 patients who were treated for mild severity COVID-19 between September 15, 2020 and December 31, 2020 were collected. 105 age and sex matched healthy subjects were included in the study. Right ventricular (RV) functions were evaluated using conventional two-dimensional (2D) echocardiography and 2D speckle-tracking echocardiography (STE) for all patients. 2D-E parameters indicating RV functions were compared between the two groups. RV diamaters, systolic pulmonary artery pressure (sPAP) and RV myocardial performance index (RV MPI) were significantly higher in the COVID-19 patients compared to control group (p < 0.05). Tricuspid annular plane systolic motion (TAPSE), right ventricular fractional area change (RVFAC) and RV S' were significantly lower in the COVID-19 group compared to control group (p < 0.05). RV global longitudinal strain (RV-GLS) (- 19.6 ± 5.2 vs. - 15.1 ± 3.4, p < 0.001) and RV free wall longitudinal strain RV-FWLS (- 19.6 ± 5.2 vs. - 17.2 ± 4.4, p < 0.001) values were significantly lower in the COVID-19 group than the control group. There was a significant negative correlation between RV-FWLS, RV-GLS and C-reactive protein (CRP), neutrophil to lymphocyte ratio (NLR), d-dimer, ferritin, platelet to lymphocyte ratio (PLR) in patients with mild severity COVID-19. This results suggested that RV-GLS and RV-FWLS decreased in the long term (third month) follow-up of patients treated for mild severity COVID-19 disease. Subclinical RV dysfunction may be observed in patients after mild severity COVID-19.
More Related Videos
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
08:21Biventricular Assessment of Cardiac Function and Pressure-Volume Loops by Closed-Chest Catheterization in Mice
Published on: June 15, 2020
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Heart Failure III: Clinical Manifestations
Myocarditis I: Introduction